Literature DB >> 20811066

Three gene-targeted mouse models of RNA splicing factor RP show late-onset RPE and retinal degeneration.

John J Graziotto1, Michael H Farkas, Kinga Bujakowska, Bertrand M Deramaudt, Qi Zhang, Emeline F Nandrot, Chris F Inglehearn, Shomi S Bhattacharya, Eric A Pierce.   

Abstract

PURPOSE: Mutations in genes that produce proteins involved in mRNA splicing, including pre-mRNA processing factors 3, 8, and 31 (PRPF3, 8, and 31), RP9, and SNRNP200 are common causes of the late-onset inherited blinding disorder retinitis pigmentosa (RP). It is not known how mutations in these ubiquitously expressed genes lead to retina-specific disease. To investigate the pathogenesis of the RNA splicing factor forms of RP, the authors generated and characterized the retinal phenotypes of Prpf3-T494M, Prpf8-H2309P knockin mice. The retinal ultrastructure of Prpf31-knockout mice was also investigated.
METHODS: The knockin mice have single codon alterations in their endogenous Prpf3 and Prpf8 genes that mimic the most common disease causing mutations in human PRPF3 and PRPF8. The Prpf31-knockout mice mimic the null alleles that result from the majority of mutations identified in PRPF31 patients. The retinal phenotypes of the gene targeted mice were evaluated by electroretinography (ERG), light, and electron microscopy.
RESULTS: The RPE cells of heterozygous Prpf3(+/T494M) and Prpf8(+/H2309P) knockin mice exhibited loss of the basal infoldings and vacuolization, with accumulation of amorphous deposits between the RPE and Bruch[b]'s membrane at age two years. These changes were more severe in the homozygous mice, and were associated with decreased rod function in the Prpf3-T494M mice. Similar degenerative changes in the RPE were detected in Prpf31(±) mice at one year of age.
CONCLUSIONS: The finding of similar degenerative changes in RPE cells of all three mouse models suggests that the RPE may be the primary cell type affected in the RNA splicing factor forms of RP. The relatively late-onset phenotype observed in these mice is consistent with the typical adult onset of disease in patients with RP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20811066      PMCID: PMC3053274          DOI: 10.1167/iovs.10-5194

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  58 in total

Review 1.  Pre-mRNA splicing: awash in a sea of proteins.

Authors:  Melissa S Jurica; Melissa J Moore
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

Review 2.  Nuclear speckles: a model for nuclear organelles.

Authors:  Angus I Lamond; David L Spector
Journal:  Nat Rev Mol Cell Biol       Date:  2003-08       Impact factor: 94.444

3.  Epidemiology of retinitis pigmentosa in Denmark.

Authors:  Marianne Haim
Journal:  Acta Ophthalmol Scand Suppl       Date:  2002

4.  Central region of the human splicing factor Hprp3p interacts with Hprp4p.

Authors:  Juana Maria Gonzalez-Santos; Anan Wang; Joses Jones; Chisato Ushida; Jun Liu; Jim Hu
Journal:  J Biol Chem       Date:  2002-04-23       Impact factor: 5.157

5.  RNAi knockdown of hPrp31 leads to an accumulation of U4/U6 di-snRNPs in Cajal bodies.

Authors:  Nina Schaffert; Markus Hossbach; Rainer Heintzmann; Tilmann Achsel; Reinhard Lührmann
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

6.  RP1 is required for the correct stacking of outer segment discs.

Authors:  Qin Liu; Arkady Lyubarsky; Jason H Skalet; Edward N Pugh; Eric A Pierce
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

7.  PAP-1, the mutated gene underlying the RP9 form of dominant retinitis pigmentosa, is a splicing factor.

Authors:  Hiroshi Maita; Hirotake Kitaura; T Jeffrey Keen; Chris F Inglehearn; Hiroyoshi Ariga; Sanae M M Iguchi-Ariga
Journal:  Exp Cell Res       Date:  2004-11-01       Impact factor: 3.905

8.  Histologic study of retinitis pigmentosa due to a mutation in the RP13 gene (PRPC8): comparison with rhodopsin Pro23His, Cys110Arg, and Glu181Lys.

Authors:  King To; Michael Adamian; Eliot L Berson
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

9.  Novel deletion in the pre-mRNA splicing gene PRPF31 causes autosomal dominant retinitis pigmentosa in a large Chinese family.

Authors:  Lejin Wang; Michael Ribaudo; Kanxing Zhao; Ning Yu; Qiuyun Chen; Qiuxiang Sun; Liming Wang; Qing Wang
Journal:  Am J Med Genet A       Date:  2003-09-01       Impact factor: 2.802

10.  A novel PRPF31 splice-site mutation in a Chinese family with autosomal dominant retinitis pigmentosa.

Authors:  Kun Xia; Duo Zheng; Qian Pan; Zheng Liu; Xinghua Xi; Zhengmao Hu; Hao Deng; Xiaoping Liu; Deyong Jiang; Hanxiang Deng; Jiahui Xia
Journal:  Mol Vis       Date:  2004-05-20       Impact factor: 2.367

View more
  36 in total

1.  Aberrant RNA splicing is the major pathogenic effect in a knock-in mouse model of the dominantly inherited c.1430A>G human RPE65 mutation.

Authors:  Yan Li; Rachel Furhang; Amanda Ray; Todd Duncan; Joseph Soucy; Rashid Mahdi; Vijender Chaitankar; Linn Gieser; Eugenia Poliakov; Haohua Qian; Pinghu Liu; Lijin Dong; Igor B Rogozin; T Michael Redmond
Journal:  Hum Mutat       Date:  2019-01-25       Impact factor: 4.878

Review 2.  RNA-Seq: Improving Our Understanding of Retinal Biology and Disease.

Authors:  Michael H Farkas; Elizabeth D Au; Maria E Sousa; Eric A Pierce
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

Review 3.  RNA Splicing and Disease: Animal Models to Therapies.

Authors:  Matías Montes; Brianne L Sanford; Daniel F Comiskey; Dawn S Chandler
Journal:  Trends Genet       Date:  2018-11-19       Impact factor: 11.639

4.  A Drosophila model to study retinitis pigmentosa pathology associated with mutations in the core splicing factor Prp8.

Authors:  Dimitrije Stanković; Ann-Katrin Claudius; Thomas Schertel; Tina Bresser; Mirka Uhlirova
Journal:  Dis Model Mech       Date:  2020-06-26       Impact factor: 5.758

5.  Mutations in pre-mRNA processing factors 3, 8, and 31 cause dysfunction of the retinal pigment epithelium.

Authors:  Michael H Farkas; Deborah S Lew; Maria E Sousa; Kinga Bujakowska; Jonathan Chatagnon; Shomi S Bhattacharya; Eric A Pierce; Emeline F Nandrot
Journal:  Am J Pathol       Date:  2014-08-08       Impact factor: 4.307

Review 6.  Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.

Authors:  Charles B Wright; Steven M Becker; Lucie A Low; Danilo A Tagle; Paul A Sieving
Journal:  J Ocul Pharmacol Ther       Date:  2019-06-05       Impact factor: 2.671

7.  PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa.

Authors:  Goranka Tanackovic; Adriana Ransijn; Philippe Thibault; Sherif Abou Elela; Roscoe Klinck; Eliot L Berson; Benoit Chabot; Carlo Rivolta
Journal:  Hum Mol Genet       Date:  2011-03-05       Impact factor: 6.150

8.  RNA Splicing Factor Mutations That Cause Retinitis Pigmentosa Result in Circadian Dysregulation.

Authors:  Iryna Shakhmantsir; Scott J Dooley; Siddharth Kishore; Dechun Chen; Eric Pierce; Jean Bennett; Amita Sehgal
Journal:  J Biol Rhythms       Date:  2019-11-15       Impact factor: 3.182

Review 9.  RNA-binding proteins in eye development and disease: implication of conserved RNA granule components.

Authors:  Soma Dash; Archana D Siddam; Carrie E Barnum; Sarath Chandra Janga; Salil A Lachke
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-05-01       Impact factor: 9.957

Review 10.  Alternative splicing and retinal degeneration.

Authors:  M M Liu; D J Zack
Journal:  Clin Genet       Date:  2013-06-05       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.